Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP1051192A2 Methods for the prevention and treatment of fibrosis and sclerosis
11/15/2000EP1051191A2 Cd154 blockade therapy for pancreatic islet tissue transplantation
11/15/2000EP1051187A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/15/2000EP0601129B1 Morphogenic protein screening method
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147194 Purified monoclonal antibody which binds inosine 5'-monophosphate dehydrogenase polypeptide which is encoded by a defined nucleotide sequence; immunoassays for detection
11/14/2000US6147191 Protein associated with mylein and the central nervous system; for the diagnosis and treatment of multiple sclerosis and autoimmune diseases
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6146903 Method for determination of water treatment polymers
11/14/2000US6146885 Plasmid for transfer of genes into vertebrate cells
11/14/2000US6146876 22025, a novel human cyclic nucleotide phosphodiesterase
11/14/2000US6146870 Flea protease proteins
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146850 Proteins encoding gelonin sequences
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146841 Methods for identifying compounds that bind to CSAPK-3 molecules and fragments thereof
11/14/2000US6146836 Immunoassays using anti-allotypic monoclonal antibodies
11/14/2000US6146832 Protein kinase molecules and uses therefor
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146824 Method for determining tumor cell adhesion
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146633 Endogenous and exogenous proteins, and fragments are chemically modified outside the body of an animal so that when injected into the animal, they produce more antibodies against the unmodified protein unmodified protein alone
11/14/2000US6146631 Administering a fusion protein comprising a gelonin prefered amino acid sequeance, a targeting sequence that allows internalization of fusion protein in the cell, internizing the fusion protein in the cell, eliminating the cell
11/14/2000US6146630 Inhibitors for the adhesion of lymphocytes to glandular cells
11/14/2000US6146629 Hybridoma cell line producing human monoclonal antibodies capable of binding to the hepatitis b virus surface antigen
11/14/2000US6146628 Biotherapeutic agents comprising recombinant PAP and PAP mutants
11/14/2000US6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066726A1 Novel cellular regulation factor tto 20
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066631A1 SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS FOR TGFβ¿1?
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066619A2 Means and methods for altering the functional properties in eukaryotic cells
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066160A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
11/09/2000WO2000066159A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000WO2000066155A1 Methods for preventing reactivation of latent virus and controlling virus replication
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037105A3 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000DE19922444A1 Verfahren zur Behandlung von TNF-Rezeptor vermittelten Krankheiten A method for the treatment of TNF-receptor-mediated diseases
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2373018A1 Novel cellular regulation factor tto 20
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000CA2371427A1 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
11/09/2000CA2371421A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2370304A1 Specific antibodies and antibody fragments for tgf.beta.1
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365278A1 Tumour-associated antigen
11/08/2000EP1050581A1 Method for detecting acetyltransferase and deacetylase activities and method for screening inhibitors or accelerators of these enzymes
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1049934A1 Specific antibodies to kringle 5 of apolipoprotein a and methods of use therefor
11/08/2000EP1049810A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/08/2000EP1049799A1 Antimicrobial compounds
11/08/2000EP1049787A1 Multipurpose antibody derivatives
11/08/2000EP1049781A1 Human chemokine and its use for detection and treatment of breast disease
1 ... 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 ... 1494